TP53 and B-cell chronic lymphocytic leukemia: Interestingly, approximately 40% (28/69) of CLL cases bearing +12, del(11q)/ATM or del(17p)/TP53 in this study exhibited an “unidentified” del(13q)/MIRN16-1/MIRN15A aberration.